Evidence map›Paper›PMID 18678666›Full record

ArticleInfection and immunity2008

TrxR, a new CovR-repressed response regulator that activates the Mga virulence regulon in group A Streptococcus.

Temekka V Leday, Kathryn M Gold, Traci L Kinkel, Samantha A Roberts, June R Scott, Kevin S McIver

Abstract read
In one paragraph

Article in Infection and immunity, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The crimson conundrum: heme toxicity and tolerance in GAS.Frontiers in cellular and infection microbiology · 2014
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Streptococcus adherence and colonization.Microbiology and molecular biology reviews : MMBR · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Temekka V LedayDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Kathryn M Gold
Traci L Kinkel
Samantha A Roberts
June R Scott
Kevin S McIver
Emory University · USThe University of Texas Southwestern Medical Center · USUniversity of Maryland, College Park · US

Funding

TRAINING THE MD PHD IN THE HEALTH SCIENCE CENTERT32GM008014 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI ZINN, ANDREW R. · 1985 to 2024
$21.1M
MOLECULAR MICROBIOLOGY TRAINING GRANTT32AI007520 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI Julie K Pfeiffer · 1997 to 2026
$7.0M
PRD-Containing Virulence Regulators of Pathogenic StreptococciR01AI047928 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI MCIVER, KEVIN S. · 2001 to 2023
$6.5M
MOLECULAR MECHANISMS OF MICROBIAL PATHOGENESIST32AI007470 · NIAID · EMORY UNIVERSITY · PI SPECK, SAMUEL H · 1995 to 2010
$3.2M
GENETIC ANALYSIS OF STREPTOCOCCAL M PROTEINR01AI020723 · NIAID · EMORY UNIVERSITY · PI SCOTT, JUNE R · 1985 to 2010
$2.7M
GENETIC ANALYSIS OF S PYOGENES VIRULENCE FACTORSR37AI020723 · NIAID · EMORY UNIVERSITY · PI SCOTT, JUNE R · 1992 to 2001
$870k
Genetica Analysis of S. Pyogenes Virulence FactorsR56AI020723 · NIAID · EMORY UNIVERSITY · PI SCOTT, JUNE R · 2008 to 2008
$465k
Genetic Analysis of S Pyogenes Virulence FactorsR21AI020723 · NIAID · EMORY UNIVERSITY · PI SCOTT, JUNE R · 2002 to 2002
$380k
NIAID NIH HHS 5T32 AI07520NIAID NIH HHS AI20723NIAID NIH HHS AI47928NIAID NIH HHS R01 AI020723NIAID NIH HHS R01 AI047928NIAID NIH HHS R21 AI020723NIAID NIH HHS R37 AI020723NIAID NIH HHS R56 AI020723NIAID NIH HHS T32 AI007470NIAID NIH HHS T32 AI007520NIAID NIH HHS T32 AI07470NIGMS NIH HHS GM08014NIGMS NIH HHS T32 GM008014
6 · The paper itself

Abstract

Coordinate regulation of virulence factors by the group A streptococcus (GAS) Streptococcus pyogenes is important in this pathogen's ability to cause disease. To further elucidate the regulatory network in this human pathogen, the CovR-repressed two-component system (TCS) trxSR was chosen for further analysis based on its homology to a virulence-related TCS in Streptococcus pneumoniae. In a murine skin infection model, an insertion mutation in the response regulator gene, trxR, led to a significant reduction in lesion size, lesion severity, and lethality. Curing the trxR mutation restored virulence comparable to the wild-type strain. The trxSR operon was defined in vivo, and CovR was found to directly repress its promoter in vitro. DNA microarray analysis established that TrxR activates transcription of Mga-regulated virulence genes, which may explain the virulence attenuation of the trxR mutant. This regulation appears to occur by activation of the mga promoter, Pmga, as demonstrated by analysis of a luciferase reporter fusion. Complementation of the trxR mutant with trxR on a plasmid restored expression of Mga regulon genes and restored virulence in the mouse model to wild-type levels. TrxR is the first TCS shown to regulate Mga expression. Because it is CovR repressed, TrxR defines a new pathway by which CovR can influence Mga to affect pathogenesis in the GAS.

Indexed as

RegulonAnimalsArtificial Gene FusionBacterial ProteinsGene DeletionGenes, ReporterGenetic Complementation TestLuciferasesMiceMutagenesis, InsertionalOligonucleotide Array Sequence AnalysisRepressor ProteinsSkin Diseases, BacterialStreptococcal InfectionsStreptococcus pyogenesSurvival AnalysisBacterial ProteinsCsrR protein, Streptococcus pyogenesLuciferasesmry protein, Streptococcus pyogenesRepressor ProteinsTranscription FactorsVirulence Factors

Identifiers

PMID18678666
PMCPMC2546847
OpenAlexW2166108368

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.